Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biochimie ; 119: 27-35, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26455266

RESUMEN

Several studies have shown that acute fluoride (F(-)) exposure impairs cardiac function, but the molecular mechanism is not clear. In order to study this, male Wistar rats were treated with single oral doses of 45 and 90 mg/kg F(-) for 24 h. A significant accumulation of F(-) was found in the serum and myocardium of experimental rats. F(-) treatment causes myocardial necrosis as evident from increased levels of myocardial troponin I, creatine kinase, lactate dehydrogenase and aspartate transaminase. In addition, F(-) induces myocardial oxidative stress via increased reactive oxygen species, lipid peroxidation, protein carbonyl content and nitrate levels along with decreased in the levels of enzymatic (superoxide dismutase 2, catalase, glutathione peroxidase and glutathione s transferase pi class) and non-enzymatic (reduced glutathione) antioxidants. Notably, F(-) triggers myocardial apoptosis through altered Bax/Bcl2 ratio and increased cytochrome c, caspase 3p20 and terminal deoxynucleotidyl transferase dUTP nick end labeled positive cells. An increased cardiac expression of Nox4 and p38α MAPK in F(-) treated rats indicates the oxidative and apoptotic damage. Moreover, ultra-structural changes, histopathological and luxol fast blue staining demonstrates the degree of myocardial damage at subcellular level. Taken together, these findings reveal that acute F(-) exposure causes cardiac impairment by altering the expression of oxidative stress, apoptosis and necrotic markers.


Asunto(s)
Apoptosis/efectos de los fármacos , Cariostáticos/envenenamiento , Intoxicación por Flúor/metabolismo , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Corazón/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Fluoruro de Sodio/envenenamiento , Administración Oral , Animales , Biomarcadores/sangre , Biomarcadores/metabolismo , Cariostáticos/administración & dosificación , Cariostáticos/metabolismo , Relación Dosis-Respuesta a Droga , Electrocardiografía/efectos de los fármacos , Intoxicación por Flúor/etiología , Intoxicación por Flúor/patología , Intoxicación por Flúor/fisiopatología , Glutatión/antagonistas & inhibidores , Glutatión/metabolismo , Corazón/fisiopatología , Masculino , Miocardio/enzimología , Miocardio/metabolismo , Miocardio/patología , Miocardio/ultraestructura , Necrosis , Oxidorreductasas/antagonistas & inhibidores , Oxidorreductasas/genética , Oxidorreductasas/metabolismo , Distribución Aleatoria , Ratas Wistar , Fluoruro de Sodio/administración & dosificación , Fluoruro de Sodio/sangre , Fluoruro de Sodio/metabolismo , Distribución Tisular , Toxicocinética , Disfunción Ventricular/etiología
2.
J Am Dent Assoc ; 136(1): 67-70; quiz 91, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15693498

RESUMEN

BACKGROUND: High-concentration topical fluorides are used commonly to with compromised salivary function due to irradiation and chemotherapy. CASE DESCRIPTION: The authors describe a 50-year-old man with previously treated cancer who was using tray-applied topical fluoride gel. He complained of gastric symptoms, difficulty in swallowing, leg muscle soreness and knee joint soreness. A computed tomographic scan revealed thickening of the esophageal walls. An upper endoscopy revealed abnormal motility. The motility test indicated high-amplitude peristalsis and hypertensive lower esophageal sphincter, and urine testing indicated high levels of systemic fluoride. The patient's fluoride regimen was altered, and within a short period his urinary fluoride levels returned to normal and his symptoms resolved. CLINICAL IMPLICATIONS: Clinicians prescribing home-applied high-concentration fluorides need to be cognizant of the symptoms of fluoride toxicity, carefully monitor the patient's compliance with the treatment regimen, and adjust the dosage or mode of application to control the total ingested dose of fluoride.


Asunto(s)
Cariostáticos/administración & dosificación , Intoxicación por Flúor/etiología , Fluoruros/administración & dosificación , Enfermedades Gastrointestinales/inducido químicamente , Xerostomía/etiología , Artralgia/inducido químicamente , Cariostáticos/envenenamiento , Irradiación Craneana/efectos adversos , Fluoruros/efectos adversos , Fluoruros/orina , Humanos , Masculino , Persona de Mediana Edad , Enfermedades Musculoesqueléticas/inducido químicamente
3.
Dent Clin North Am ; 46(4): 831-46, xi, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12436834

RESUMEN

The current health care trend is to provide evidence-based recommendations and treatment. Many literature reviews have shown fluoride's effectiveness against caries. The current use of fluoride in the prevention of dental caries is based on community, professional, and individual strategies. Personalized fluoride regimens should include a risk analysis and a review of the patient's current fluoride exposure. The future of fluoride may be found in its slow release and retention in the oral cavity through various modalities. Because of the many uncertainties still associated with fluoride, further research is needed.


Asunto(s)
Cariostáticos/uso terapéutico , Fluoruros/uso terapéutico , Adolescente , Cariostáticos/administración & dosificación , Cariostáticos/farmacocinética , Cariostáticos/envenenamiento , Niño , Preescolar , Protocolos Clínicos , Preparaciones de Acción Retardada , Caries Dental/prevención & control , Materiales Dentales/química , Suplementos Dietéticos , Medicina Basada en la Evidencia , Intoxicación por Flúor/prevención & control , Fluoruros/administración & dosificación , Fluoruros/farmacocinética , Fluoruros Tópicos/administración & dosificación , Fluoruros Tópicos/uso terapéutico , Geles , Humanos , Lactante , Recién Nacido , Laca , Medicamentos sin Prescripción/uso terapéutico , Medición de Riesgo , Autoadministración , Pastas de Dientes/uso terapéutico
4.
Dent Clin North Am ; 43(4): 695-711, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10553251

RESUMEN

Fluoride may be ingested from a variety of sources, including many foods and beverages. Fluoride intake varies greatly among individuals and is dependent on dietary constituents and use of fluoride products. Although ingestion of toxic amounts of fluoride is rare, the prevalence of dental fluorosis has increased in North America, suggesting that the levels of fluoride ingestion need to be closely monitored. Care should be taken to avoid excessive ingestion of fluoride dentifrice by preschool-aged children by placement of a small, pea-sized quantity on the tooth-brush. Dietary fluoride supplements should be considered a targeted, preventive procedure only for those at elevated caries risk, and before prescribing them, careful consideration should be given to other fluoride sources, including home and child-care water supplies, foods, and beverages.


Asunto(s)
Cariostáticos/uso terapéutico , Caries Dental/prevención & control , Fluoruros/uso terapéutico , Administración Oral , Bebidas , Cariostáticos/administración & dosificación , Cariostáticos/efectos adversos , Cariostáticos/análisis , Cariostáticos/envenenamiento , Preescolar , Susceptibilidad a Caries Dentarias , Dentífricos/uso terapéutico , Intoxicación por Flúor/etiología , Fluoruros/administración & dosificación , Fluoruros/efectos adversos , Fluoruros/análisis , Fluorosis Dental/etiología , Alimentos , Humanos , Cepillado Dental , Abastecimiento de Agua/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA